Italy: Diesse Diagnostica develops blood test for Covid-19 detection

Diesse Diagnostica, a portfolio company of Italian healthcare investment firm Archimed, is developing a blood test for Covid-19 detection.  The test will be able to indicate whether someone has ever had Covid-19 or is a carrier without symptoms, whereas more common testing only shows whether someone displaying symptoms has Covid-19. The test will be distributed…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »